cardiovascular disease

Fresh analysis spotlights cardio benefit of J&J's Invokana in diabetes patients without history of CV disease
Endpoints
Wed, 06/12/19 - 10:02 am
JNJ
Invokana
ADA
diabetes
cardiovascular disease
Highlights: 2019 Cardiometabolic Health Congress West
CP Wire
Fri, 05/17/19 - 10:47 am
diabetes
heart disease
cardiometabolic health
heart failure
cardiovascular disease
IBM’s AI-aided fingernail sensor could help with cardio, Parkinson’s treatment
Mass Device
Fri, 12/21/18 - 04:14 pm
IBM
devices
fingernail sensors
Parkinson's Disease
cardiovascular disease
artificial intelligence
Edwards Lifesciences, Bay Labs ink cardio-focused collab AI-dev deal
Mass Device
Mon, 12/10/18 - 11:57 am
devices
cardiovascular disease
Edwards Lifesciences
Bay Labs
artificial intelligence
Farxiga Meets One Primary Endpoint in Large Ph III Cardiovascular Outcomes Trial in 17,000 Patients with Type 2 Diabetes
CP Wire
Mon, 09/24/18 - 10:01 am
AstraZeneca
Farxiga
Dapagliflozin
clinical trials
type 2 diabetes
cardiovascular disease
3 Headwinds in Q4 Earnings Results That Make Merck a Mediocre Stock
Motley Fool
Sun, 02/4/18 - 11:44 am
Merck
earnings
diabetes
cardiovascular disease
vaccines
3 Medtech Markets That Are Showing Growth
Medical Devices and Diagnostics Industry
Wed, 01/24/18 - 09:22 am
devices
diagnostics
cardiovascular disease
Orthopedics
Insurers, doctors battle over new heart disease drugs
CNBC
Fri, 09/8/17 - 09:30 am
insurers
cardiovascular disease
statins
PCSK9 inhibitors
Amgen
Regeneron
Sanofi
Repatha
Praluent
Big pharma stands to make hundreds of billions of dollars from a handful of medical conditions
Motley Fool
Thu, 09/7/17 - 09:56 am
Big Pharma
viral hepatitis
respiratory disease
autoimmune disease
cardiovascular disease
pain
diabetes
cancer
Novartis shares slip after mixed heart drug data
Yahoo/Reuters
Mon, 08/28/17 - 09:33 am
Novartis
canakinumab
Ilaris
cardiovascular disease
Novo’s Victoza, new indication to reduce CV risk
GoInPharma
Sun, 08/27/17 - 06:24 pm
Novo Nordisk
Victoza
diabetes
cardiovascular disease
Novartis returns to the discount aisle, buys Xoma’s failed PhIII drug for $31M
Endpoints
Fri, 08/25/17 - 09:53 am
Novartis
Xoma
M&A
gevokizumab
cardiovascular disease
King cancer: The top 10 therapeutic areas in biopharma R&D
Endpoints
Tue, 07/18/17 - 10:49 pm
R&D
cancer
neurology
infection
immunology
cardiovascular disease
diabetes
Sanofi’s Unique Foothold in Diabetes and Cardiovascular
Market Realist
Mon, 02/20/17 - 09:54 am
Sanofi
diabetes
cardiovascular disease
Drug Development Is Lagging For The World's Leading Killer
Forbes
Tue, 08/30/16 - 10:03 am
R&D
cardiovascular disease
AstraZeneca’s CVMD Segment: How Did It Perform in 2Q15?
Yahoo/Market Realist
Wed, 08/26/15 - 10:43 am
AstraZeneca
cardiovascular disease
metabolic disorders
Onglyza
Crestor
Brilinta
2 Cell Therapy Companies That Could Thrive With Cardiovascular Disease Treatments
Seeking Alpha
Mon, 02/24/14 - 11:11 am
stem cells
cardiovascular disease
Athersys
NeoStem
AMR-001
MultiStem
The Surprising Company Taking On America's Most Fatal Disease
Motley Fool
Fri, 11/1/13 - 11:46 am
Ranexa
Gilead Sciences
angina
cardiovascular disease
Sanofi will sell Pozen cardiovascular drugs in US
Yahoo/AP
Thu, 09/5/13 - 08:20 am
Sanofi
Pozen
cardiovascular disease
PA8140
PA32540
Pozen announces results of sponsored study on cardiovascular disease
Yahoo/Fly on the Wall
Fri, 04/5/13 - 10:51 am
Pozen
cardiovascular disease
Xcenda

Pages